𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐇𝐞𝐦𝐚𝐭𝐨 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟐𝟓-𝟐𝟎𝟑𝟓)



𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐃- https://lnkd.in/dFzurnhW

The North America hemato oncology testing market is set for strong growth over the forecast period. From an estimated USD 1,150 million in 2025, the market is forecasted to achieve USD 2,940 million by 2035. This performance is sustained by the rise in cancer cases, rapid innovation in NGS and PCR-based assays, and expanded adoption in both large cancer centers and community hospitals. Year-on-year revenue progression highlights significant investments by market leaders, continuous catchup from emerging companies, and a gradually widening consumer (patient) base benefiting from more accessible, affordable molecular diagnostics.

Key Drivers
Rising Incidence of Blood Cancers: The increasing prevalence of leukemia, lymphoma, and myeloma in North America is fueling demand for advanced hemato oncology testing. For example, Roche launched updated NGS panels for myeloid malignancies in June 2024, addressing early detection and personalized treatment needs.
Technological Advancements: Innovations such as automated PCR and NGS platforms are accelerating diagnostics. In July 2024, Illumina introduced a new liquid biopsy NGS solution for hematological cancers, enhancing sensitivity and workflow integration.

Key Trends
Shift Toward Comprehensive Genomic Profiling: Multi-omic and extensive panels are now preferred to enable precise cancer subtype differentiation. Thermo Fisher Scientific, in August 2024, expanded their Oncomine portfolio for blood cancers, reflecting this trend.
Integration of Artificial Intelligence (AI): AI-driven data interpretation tools are becoming central to labs. Adaptive Biotechnologies unveiled an AI-powered platform in July 2024 that improves clonality assessment in lymphoid malignancies.

Market Insights & Segmentation
Type (Assays and Kits, Services),
Application (Leukemia, Lymphoma, Myeloma, Others),
Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Others),
Technology (PCR, NGS, IHC, FISH, Cytogenetics, Other Technologies),
Organization Size (Small, Medium, Large)

Key Market Companies
F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen N.V., Agilent Technologies, Inc., Sysmex Corporation, Danaher Corporation, Invitae Corporation, PierianDx, Adaptive Biotechnologies, ArcherDX (A part of Invitae), Asuragen, Inc., NeoGenomics Laboratories, Inc.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬- https://lnkd.in/ddpidcX8 

Comments

Post a Comment

Popular posts from this blog

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐍𝐞𝐰𝐛𝐨𝐫𝐧 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟐𝟓-𝟐𝟎𝟑𝟓)

Image
𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐃- https://lnkd.in/dgM4Yq8y The North America newborn screening market is witnessing robust growth, with revenue increasing from 980 Million USD in 2020 to 1,370 Million USD in 2025, ultimately projected to reach 2,230 Million USD by 2035. This growth trajectory is attributed to increased test volumes, expanding screening panels, and greater public health investments. The upward trend underscores the region's commitment to improving neonatal health outcomes through early and comprehensive diagnostic programs, further supported by rapid technological innovation. Key Drivers Rising prevalence of congenital disorders and mandatory government regulations across the US and Canada are driving hospitals and laboratories to boost screening volumes. In 2024, PerkinElmer Inc. expanded its reagent kit offerings to meet regulatory inclusions for Cystic Fibrosis and Sickle Cell Disease screening. Key Trends Adoption of multiplex testing technologies is accelerating, allowi...
Read more

𝐔𝐒 𝐒𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐚𝐥 𝐀𝐝𝐡𝐞𝐬𝐢𝐯𝐞 𝐓𝐚𝐩𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝟐𝟎𝟑𝟓 - 𝐒𝐖𝐎𝐓 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧𝐬

Image
  𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐃- https://bussinessinsights.com/rd/chemical-&-material/us-structural-adhesive-tapes-market   The US structural adhesive tapes market is expected to demonstrate consistent growth, with total revenue rising from $1,900 million in 2020 to a projected $4,320 million by 2035. The surge in demand is attributable to rapid industrial advancements, emphasis on sustainability, and new applications across critical sectors. 2025 is estimated at $2,450 million, showing a clear upward trend, with further acceleration anticipated due to innovation in product offerings and expansion in end-user industries. Sustained R&D investment and adaptation to regulatory changes will underpin long-term growth.   Key Drivers Growth in the automotive and aerospace sectors, where structural adhesive tapes are replacing mechanical fasteners for improved assembly efficiency, reduced weight, and enhanced safety. For example, 3M has launched new lightweight bonding...
Read more

Electronic Expansion Valves (EEV) Industry - Strategy Analysis

  The global sales of electronic expansion valves are estimated to be worth USD 886.5 million in 2025 and are anticipated to reach a value of USD 1,986.0 million by 2035. Sales are projected to rise at a CAGR of 8.4% over the forecast period between 2025 and 2035. The revenue generated by electronic expansion valves in 2024 was USD 817.8 million. The industry is anticipated to exhibit a Y-o-Y growth of 8.8% in 2025. Electronic expansion valves (EEVs) are critical components in refrigeration and HVAC systems, as they control the amount of refrigerant flowing into the evaporator but in intelligent way considering the feedback provided during the operation. Unlike traditional valves, EEVs utilize electronic control mechanisms to optimize system performance, ensuring efficient heat transfer and maintaining desired conditions. The expansion valves’ capacity to self-adjust with dynamic loads also improves energy efficiency and curbs costs, which, aligning with modern energy-saving g...
Read more